AP NEWS
ADVERTISEMENT
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from PR Newswire
Press release content from PR Newswire. The AP news staff was not involved in its creation.

Gravity Diagnostics Expands Diagnostic Product Offerings by Launching Blood Testing

July 7, 2021 GMT

COVINGTON, Ky., July 7, 2021 /PRNewswire/ -- Gravity Diagnostics announces another expansion of their diagnostic product offerings with the addition of blood testing. Gravity currently serves over 1,000 customers nationwide, some of which include private practices, urgent cares, rehab and addiction clinics, pain management, and more. In July 2016, Gravity specialized primarily in toxicology testing, but quickly added pharmacogenomics, sexually transmitted infection testing, upper respiratory testing and emerged as an industry leader over the last year by responding to the COVID-19 pandemic. As Gravity continues to scale and build for the future, the addition of blood testing is an important milestone to be able to be a full-service solution for clients in all 50 states.

COVID-19 antibody testing was Gravity’s first foray into blood, which was quickly launched during the height of the pandemic to round out the comprehensiveness of their COVID-19 program, which already included gold standard PCR COVID-19 testing, antibody testing collection services, implementation of a courier fleet and same-day turnaround time they were already offering. Gravity quickly built upon that platform and now also offers a new menu of blood tests, to monitor and screen for a variety of conditions including cardiovascular diseases, hepatic, and renal function, clotting disorders, endocrine disorders, and infectious diseases, including HIV. Additional offerings will also be added this year, including, but not limited to bloodspot, tuberculosis, hormone, and UTI testing.

ADVERTISEMENT

“At Gravity, our foundation is built upon anticipating the needs and pain points of those we serve. Our team is comprised of a unique blend of individuals with expertise in patient-facing clinical care, laboratory execution, research and development, operations, sales, IT, and customer service excellence that has been instrumental in our success entering a market that was once considered a “me too,” service. The addition of blood testing is just another example of Gravity responding to the demand we see, feel and hear within the healthcare setting as it stands today,” said Julie Brazil, Co-Founder, and COO of Gravity Diagnostics.

To learn more about Gravity Diagnostics testing services, please call (855) 841-7111 or email info@gravitydiagnostics.com.

About Gravity Diagnostics
Gravity Diagnostics is a state-of-the-art CAP Accredited and CLIA Certified laboratory licensed in all 50 states providing innovative laboratory testing in the areas of COVID-19, Upper Respiratory, Toxicology, Pharmacogenomics, Sexually Transmitted Infections, and Blood. We are an advocate for physicians, patients, and our communities, supporting them with unsurpassed integrity, regulatory compliance, and clinical expertise. Gravity currently serves over 1,000 customers from small private practices to universities to Fortune 500 companies.

ADVERTISEMENT

Media Contact: media@gravitydiagnostics.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/gravity-diagnostics-expands-diagnostic-product-offerings-by-launching-blood-testing-301327138.html

SOURCE Gravity Diagnostics